| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
4,843 |
3,485 |
$4.69M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
12,436 |
10,172 |
$717K |
| 92134 |
|
13,688 |
11,586 |
$298K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
4,404 |
3,573 |
$285K |
| J9035 |
Injection, bevacizumab, 10 mg |
2,962 |
2,384 |
$237K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
1,683 |
1,350 |
$81K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,124 |
1,011 |
$69K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
44 |
40 |
$68K |
| Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg |
40 |
40 |
$39K |
| J7999 |
Compounded drug, not otherwise classified |
519 |
423 |
$22K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
153 |
144 |
$17K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
256 |
227 |
$12K |
| 92235 |
|
126 |
102 |
$7K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
54 |
51 |
$5K |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
229 |
189 |
$0.00 |
| 2022F |
|
15 |
13 |
$0.00 |